Related references
Note: Only part of the references are listed.Effect of Thrombin Inhibitors on Positive Feedback in the Coagulation Cascade
N. B. Ustinov et al.
BIOCHEMISTRY-MOSCOW (2016)
G-Quadruplex Aptamers to Human Thrombin Versus Other Direct Thrombin Inhibitors: The Focus on Mechanism of Action and Drug Efficiency as Anticoagulants
Elena Zavyalova et al.
CURRENT MEDICINAL CHEMISTRY (2016)
Development of Antithrombotic Aptamers: From Recognizing Elements to Drugs
Elena Zavyalova et al.
CURRENT PHARMACEUTICAL DESIGN (2016)
Specific antidotes against direct oral anticoagulants: A comprehensive review of clinical trials data
Ramyashree Tummala et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2016)
Translation and Clinical Development of Antithrombotic Aptamers
Shahid M. Nimjee et al.
NUCLEIC ACID THERAPEUTICS (2016)
Modulation of the Coagulation Cascade Using Aptamers
Rebecca S. Woodruff et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2015)
Anticoagulation Drug Therapy: A Review
Katherine Harter et al.
WESTERN JOURNAL OF EMERGENCY MEDICINE (2015)
Evaluation of Antithrombotic Activity of Thrombin DNA Aptamers by a Murine Thrombosis Model
Elena Zavyalova et al.
PLOS ONE (2014)
Argatroban versus Lepirudin in critically ill patients (ALicia): a randomized controlled trial
Tanja A. Treschan et al.
CRITICAL CARE (2014)
Development and validation of a highly sensitive LC-MS/MS method for quantitation of bivalirudin in human plasma: application to a human pharmacokinetic study
Dong Chai et al.
BIOMEDICAL CHROMATOGRAPHY (2013)
Module-Activity Relationship of G-quadruplex Based DNA Aptamers for Human Thrombin
E. Zavyalova et al.
CURRENT MEDICINAL CHEMISTRY (2013)
Investigational anticoagulants for hematological conditions: a new generation of therapies
Gentian Denas et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2013)
Selection of an Aptamer Antidote to the Anticoagulant Drug Bivalirudin
Jennifer A. Martin et al.
PLOS ONE (2013)
A new paradigm shift in antithrornbotic therapy
Anita Pudusseri et al.
FRONTIERS IN PHARMACOLOGY (2013)
Population pharmacokinetics and pharmacodynamics of bivalirudin in young healthy Chinese volunteers
Dong-mei Zhang et al.
ACTA PHARMACOLOGICA SINICA (2012)
DNA Aptamers for Human Thrombin with High Anticoagulant Activity Demonstrate Target- and Species-Specificity
E. Zavyalova et al.
CURRENT MEDICINAL CHEMISTRY (2012)
Novel Modular DNA Aptamer for Human Thrombin with High Anticoagulant Activity
E. Zavyalova et al.
CURRENT MEDICINAL CHEMISTRY (2011)
Leech-Derived Thrombin Inhibitors: From Structures to Mechanisms to Clinical Applications
Maria Angeles Corral-Rodriguez et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
Aptamers as therapeutics
Anthony D. Keefe et al.
NATURE REVIEWS DRUG DISCOVERY (2010)
Direct thrombin inhibitors - a survey of recent developments
A. Schwienhorst
CELLULAR AND MOLECULAR LIFE SCIENCES (2006)
What does it take to make the perfect clot?
DM Monroe et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2006)
Pharmacokinetics and biodistribution of novel aptamer compositions
JM Healy et al.
PHARMACEUTICAL RESEARCH (2004)
Regulatable aptamers in medicine: focus on antithrombotic strategies
A Potti et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2004)
Bivalirudin pharmacokinetics and pharmacodynamics: Effect of renal function, dose, and gender
R Robson et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2002)
Share Paper
